XL019

DRUG2 trials

Sponsors

Exelixis

Conditions

MyelofibrosisMyeloproliferative DisordersPolycythemia VeraThrombocythemia, Essential

Phase 1

A Safety Study of XL019 in Adults With Myelofibrosis

TerminatedNCT00522574

ExelixisMyelofibrosis, Myeloproliferative Disorders, Polycythemia Vera +1

Start: 2007-08-31Target: 100Updated: 2011-04-05

A Phase 1 Study of XL019 in Adults With Polycythemia Vera

TerminatedNCT00595829

ExelixisPolycythemia Vera

Start: 2007-12-31End: 2009-02-28Updated: 2015-08-21